138 related articles for article (PubMed ID: 9759700)
21. Gamma Irradiated
Xin Q; Kwon MJ; Lee JW; Kim KS; Chen H; Campos MG; Tundis R; Cui CB; Cho YH; Cao H
Molecules; 2019 Nov; 24(21):. PubMed ID: 31689885
[TBL] [Abstract][Full Text] [Related]
22. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
[TBL] [Abstract][Full Text] [Related]
23. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
[TBL] [Abstract][Full Text] [Related]
24. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
25. Role of reductase and aromatase in sex determination in the red-eared slider (Trachemys scripta), a turtle with temperature-dependent sex determination.
Crews D; Bergeron JM
J Endocrinol; 1994 Nov; 143(2):279-89. PubMed ID: 7829992
[TBL] [Abstract][Full Text] [Related]
26. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
27. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.
Rittmaster RS; Manning AP; Wright AS; Thomas LN; Whitefield S; Norman RW; Lazier CB; Rowden G
Endocrinology; 1995 Feb; 136(2):741-8. PubMed ID: 7835306
[TBL] [Abstract][Full Text] [Related]
28. Potential activities of androgen metabolizing enzymes in human prostate.
Krieg M; Weisser H; Tunn S
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
[TBL] [Abstract][Full Text] [Related]
29. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
Gloyna RE; Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
[TBL] [Abstract][Full Text] [Related]
31. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
32. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Lima CB; Angrimani DSR; Flores RB; Vannucchi CI
Domest Anim Endocrinol; 2021 Apr; 75():106601. PubMed ID: 33333452
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging of the efficacy of specific inhibition of 5 alpha-reductase in canine spontaneous benign prostatic hyperplasia.
Cohen SM; Taber KH; Malatesta PF; Shpungin J; Berman C; Carlin JR; Werrmann JG; Prahalada S; Bryan RN; Cordes EH
Magn Reson Med; 1991 Sep; 21(1):55-70. PubMed ID: 1719333
[TBL] [Abstract][Full Text] [Related]
34. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
McConnell JD; Wilson JD; George FW; Geller J; Pappas F; Stoner E
J Clin Endocrinol Metab; 1992 Mar; 74(3):505-8. PubMed ID: 1371291
[TBL] [Abstract][Full Text] [Related]
35. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.
Nakayama O; Hirosumi J; Chida N; Takahashi S; Sawada K; Kojo H; Notsu Y
Prostate; 1997 Jun; 31(4):241-9. PubMed ID: 9180934
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
37. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Geller J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
[TBL] [Abstract][Full Text] [Related]
38. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
Jia Y; Cue YG; Wang XD; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):38-41. PubMed ID: 15704680
[TBL] [Abstract][Full Text] [Related]
39. Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.
Prahalada SR; Keenan KP; Hertzog PR; Gordon LR; Peter CP; Soper KA; van Zwieten MJ; Bokelman DL
Urology; 1994 May; 43(5):680-5. PubMed ID: 7513109
[TBL] [Abstract][Full Text] [Related]
40. Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
Jaffe A; Matzkin H; Gilad S; Stern N
Horm Res; 1994; 41(5-6):215-7. PubMed ID: 7525442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
